As Mac‐1 controls the activation of neutrophils or platelets, inhibition of Mac‐1 function in ALI may be a therapeutic strategy for preventing NETs formation in patients with ALI. This evidence concerns the gene ITGB2 and acute respiratory distress syndrome.